Healthcare -
Biotechnology - NASDAQ - US
$ 0.371
-11.7 %
$ 1.8 M
Market Cap
-0.01
P/E
PBLA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PBLA - Panbela Therapeutics, Inc.
26.1 M
LAST VALUE
60.92%
2 YEAR CAGR
48.31%
5 YEAR CAGR
116.41%
10 YEAR CAGR